High-Profile Brain Tumor Therapy Trial Chooses University of Connecticut Health
March 05, 2021
March 05, 2021
STORRS, Connecticut, March 5 (TNSRes) -- The University of Connecticut issued the following news:
As a promising new therapy for certain brain tumors reaches the second phase of clinical trials, UConn Health will be one of the select few locations in the United States to make this treatment available to patients during the further evaluation of its safety and efficacy.
The therapy combines what researchers are calling PVSRIPO, a viral immunotherapy based on the polio va . . .
As a promising new therapy for certain brain tumors reaches the second phase of clinical trials, UConn Health will be one of the select few locations in the United States to make this treatment available to patients during the further evaluation of its safety and efficacy.
The therapy combines what researchers are calling PVSRIPO, a viral immunotherapy based on the polio va . . .